• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
5-6 samples? That’s incredibly low in comparison to the work they once brought in, courtesy to the sales reps they once had.
Are you even buying into this ex employee crap? You’re right 5-6 samples couldn’t even pay for toilet paper !

I’m not saying Ammon is thriving ! But if you look back in these threads - since 2018, over 5 years of false rumors, ex employees posting bitter crap, legitimate investigations from DOJ because of false accusations from bitter employees - I mean really - look at it all. No shutting down, no arrests, successful chapter 11. All the hatred ! All the bitterness. All for nothing - all these angry people - you didn’t hurt the Haupt’s - they are thriving! You hurt the really really loyal and valued former employees of Ammon. A few bitter jealous people posted propaganda, people latched on. It was completely unnecessary.
 








Are you even buying into this ex employee crap? You’re right 5-6 samples couldn’t even pay for toilet paper !

I’m not saying Ammon is thriving ! But if you look back in these threads - since 2018, over 5 years of false rumors, ex employees posting bitter crap, legitimate investigations from DOJ because of false accusations from bitter employees - I mean really - look at it all. No shutting down, no arrests, successful chapter 11. All the hatred ! All the bitterness. All for nothing - all these angry people - you didn’t hurt the Haupt’s - they are thriving! You hurt the really really loyal and valued former employees of Ammon. A few bitter jealous people posted propaganda, people latched on. It was completely unnecessary.

Successful Chapter 11? Ammon is a shell of their former selves. They have about $5-6m in business down from $50M at their high. They had to sell their Mass lab due to OIG issues with billing thru a hospital, had IRS issues due to the foundation, have an HRSA audit ongoing and from I am told have issue again with OIG for illegal billing and splitting of profits by billing through a hospitals contracts. How are the Haupts thriving?
 




From ex-sales person who still has contacts at Ammon. Issue started in Mass lab but now further investigation found issue at Linden.

Doesn’t this doing another alarm? It’s old stuff with Ammon and their woes, most expect it.

FYI, PBS was just an acronym for everyone confused just wording that confused most.
 




Doesn’t this doing another alarm? It’s old stuff with Ammon and their woes, most expect it.

FYI, PBS was just an acronym for everyone confused just wording that confused most.

Doesn’t this sound another alarm? It’s old stuff with Ammon and their woes, most expect it.

FYI, PBS was just an acronym for everyone confused just wording that confused most.
 








Is everyone wrong about the downfall of Ammon and other labs? It always seems like there’s one good praise for the million bad ones.

Genuine question here.

I don’t think anyone can hide the stark reality of what toxicology labs are facing right now. Things aren’t as ideal as they once were…